ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; aminoacetic acid; calcium chloride dihydrate; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- leucine; l- lysine acetate; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium sulfate heptahydrate; olive oil; potassium chloride; sodium acetate trihydrate; sodium glycerophosphate hydrate; soya oil; taurine; triglycerides, medium-chain; zinc sulfate heptahydrate - תחליב לאינפוזיה - glucose monohydrate 143 g / 1000 ml; soya oil 60 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; olive oil 50 g / 1000 ml; fish oil 30 g / 1000 ml; l- alanine 14.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l- leucine 7.4 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- serine 6.5 g / 1000 ml; taurine 1.0 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- valine 6.2 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; sodium glycerophosphate hydrate 4.18 g / 1000 ml; magnesium sulfate heptahydrate 2.47 g / 1000 ml; potassium chloride 4.48 g / 1000 ml; sodium acetate trihydrate 5.62 g / 1000 ml; zinc sulfate heptahydrate 0.023 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml - parenteral nytrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; aminoacetic acid; calcium chloride dihydrate; fish oil; glucose monohydrate; glucose monohydrate; l- alanine; l- isoleucine; l- leucine; l- lysine acetate; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium sulfate heptahydrate; olive oil; potassium chloride; sodium acetate trihydrate; sodium glycerophosphate hydrate; soybean oil; taurine; triglycerides, medium-chain; zinc sulfate heptahydrate - תחליב לאינפוזיה - l- alanine 14.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l- leucine 7.4 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- serine 6.5 g / 1000 ml; taurine 1.0 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- valine 6.2 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; sodium glycerophosphate hydrate 4.18 g / 1000 ml; magnesium sulfate heptahydrate 2.47 g / 1000 ml; potassium chloride 4.48 g / 1000 ml; sodium acetate trihydrate 5.62 g / 1000 ml; zinc sulfate heptahydrate 0.023 g / 1000 ml; soybean oil 60 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; olive oil 50 g / 1000 ml; fish oil 30 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml - combinations

ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; aminoacetic acid; calcium chloride dihydrate; fish oil; glucose monohydrate; glucose monohydrate; l- alanine; l- isoleucine; l- leucine; l- lysine acetate; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium sulfate heptahydrate; olive oil; potassium chloride; sodium acetate trihydrate; sodium glycerophosphate hydrate; soybean oil; taurine; triglycerides, medium-chain; zinc sulfat - תחליב לאינפוזיה - calcium chloride dihydrate 0.74 g / 1000 ml; zinc sulfate heptahydrate 0.023 g / 1000 ml; sodium glycerophosphate hydrate 4.18 g / 1000 ml; sodium acetate trihydrate 5.62 g / 1000 ml; potassium chloride 4.48 g / 1000 ml; soybean oil 60 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; magnesium sulfate heptahydrate 2.47 g / 1000 ml; l- serine 6.5 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- leucine 7.4 g / 1000 ml; fish oil 30 g / 1000 ml; l-histidine 3.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; taurine 1.0 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; oliv - combinations

ישראל - עברית - Ministry of Health

inovamed ltd - ramipril - טבליה - ramipril 10 mg - ramipril

ישראל - עברית - Ministry of Health

inovamed ltd - ramipril - טבליה - ramipril 2.5 mg - ramipril

ישראל - עברית - Ministry of Health

inovamed ltd - ramipril - טבליה - ramipril 5 mg - ramipril

ישראל - עברית - Ministry of Health

inovamed ltd - ondansetron as hydrochloride dihydrate 2 mg / 1 ml - solution for injection - ondansetron - adults:ondansetron inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron inovamed is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:ondansetron inovamed is indicated for the management of chemotherapy-induced nausea and vomiting (cinv) in children aged ?6 months, and for the prevention and treatment of ponv in children aged ?2 years.

ישראל - עברית - Ministry of Health

inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable

ישראל - עברית - Ministry of Health

inovamed ltd - exemestane 25 mg - film coated tablets - exemestane - exemestane inovamed is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. exemestane inovamed is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. exemestane inovamed is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ישראל - עברית - Ministry of Health

inovamed ltd - montelukast as sodium 5 mg - chewable tablets - montelukast - montelukast inovamed is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.montelukast inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 to 14 years of age.